Skip over global navigation links

Video conferencing

5/21/2015
Precision Medicine Initiative Working Group Meeting

For more information go to http://acd.od.nih.gov

Air date: 5/29/2015 8:00:00 AM


5/21/2015

Precision Medicine Initiative Working Group Meeting

Air date: 5/28/2015 8:30:00 AM


5/21/2015

This 2015 NIH & FDA Glycosciences Research Day meeting explores the important roles glycans and the lectins that bind them play in Virology, Immunity, Infection, Development, and Disease.

For more information go to https://meetings.nigms.nih.gov/?ID=19237

Air date: 5/28/2015 8:30:00 AM


5/21/2015

Immunology Interest Group

Dr. Karolina Palucka is an internationally recognized clinical oncologist and cancer immunologist. She joined The Jackson Laboratory for Genomic Medicine (JAX) as professor and associate director of cancer immunology in 2014. Prior to joining JAX, Karolina was the Michael A.E. Ramsay Chair for Cancer Immunology Research and director of the Ralph M. Steinman Center for Cancer Vaccines at the Baylor Institute for Immunology Research in Dallas, where she was principal investigator of a large research award from the Human Immunology Project Consortium. She is also professor of oncological sciences and clinical immunology at Mt. Sinai School of Medicine in New York. Karolina is a leader in the field of cancer immunotherapy. Her research exploits dendritic cells, which control the body’s immune response to tumors, as the basis for new vaccines against melanomas and other human cancers. By combining outstanding cutting-edge immunology and experimental models, including humanized mice, with human trials, she is advancing the field of cancer immunotherapy and her talks bring together basic and translational work into an exciting whole.

For more information go to http://sigs.nih.gov/immunology/Pages/default.aspx

Air date: 5/27/2015 4:15:00 PM


5/21/2015

National Library of Medicine Informatics Lecture Series

There is an urgent need to translate genome-era discoveries into clinical utility, but the difficulties in making bench-to-bedside translations have been well described. The nascent field of translational bioinformatics may help. Dr. Butte's lab builds and applies computational tools to convert hundreds of trillions of points of molecular, clinical, and epidemiological data collected by researchers and clinicians worldwide over the past decade, now commonly known as “big data”, into new diagnostics, therapeutics, and insights into rare and common diseases. Dr. Butte, a bioinformatician and pediatric endocrinologist, will highlight how publicly-available molecular measurements to find new uses for drugs including drug repositioning for inflammatory bowel disease, discovering new treatable inflammatory mechanisms of disease in type 2 diabetes, and how the next generation of biotech companies might even start in your garage.

Atul Butte, MD, PhD is the founding Director of the newly-established Institute of Computational Health Sciences at the University of California, San Francisco, and a Professor of Pediatrics. Prior to his new position, he was the chief of the Division of Systems Medicine and Associate Professor of Pediatrics at Stanford University and Lucile Packard Children’s Hospital, where he has been a faculty member for the past decade. Trained in both Computer Science and Medicine at Brown University, Dr. Butte previously worked as a software engineer at Apple Inc. and Microsoft Corp., and received his PhD in Health Sciences and Technology from Harvard Medical School and MIT. He has authored nearly 200 publications, with research repeatedly featured in the New York Times, and the Wall Street Journal and Wired Magazine. In 2013, Dr. Butte was recognized by the White House as an Open Science Champion of Change for promoting science through publicly available data. Dr. Butte is also a founder of several Bay Area biotech startup companies. He is also a member of the National Library of Medicine Biomedical Library and Informatics Review Committee.

Air date: 6/3/2015 2:00:00 PM


5/18/2015

The National Heart, Lung, and Blood Institute hosts a Sickle Cell Disease Forum on June 25-26, 2015 at the National Institutes of Health (NIH) campus in Bethesda, MD. The Forum is designed to bring together sickle cell disease community stakeholders—including patients and their families, advocates, health care professionals, researchers, professional and community organizations, policymakers, government agencies, industry, and the media — to help chart the future of sickle cell disease research.

Panel sessions will address issues affecting those living with sickle cell disease, as well the potential role of various stakeholders in addressing these issues, including:

• Sickle Cell Disease Research: Past, Present, and Future
• Managing Sickle Cell Disease Pain
• Innovative Care Models
• Sickle Cell Disease Transitions
• Importance of Clinical Trails

Air date: 6/26/2015 9:00:00 AM


5/18/2015

The National Heart, Lung, and Blood Institute hosts a Sickle Cell Disease Forum on June 25-26, 2015 at the National Institutes of Health (NIH) campus in Bethesda, MD. The Forum is designed to bring together sickle cell disease community stakeholders—including patients and their families, advocates, health care professionals, researchers, professional and community organizations, policymakers, government agencies, industry, and the media — to help chart the future of sickle cell disease research.

Panel sessions will address issues affecting those living with sickle cell disease, as well the potential role of various stakeholders in addressing these issues, including:

• Sickle Cell Disease Research: Past, Present, and Future
• Managing Sickle Cell Disease Pain
• Innovative Care Models
• Sickle Cell Disease Transitions
• Importance of Clinical Trails

Air date: 6/25/2015 12:00:00 PM


5/7/2015

ICCVAM’s goals include promotion of national and international partnerships between governmental and nongovernmental groups, including academia, industry, advocacy groups, and other key stakeholders. To foster these partnerships, ICCVAM holds annual public forums to share information and facilitate direct communication of ideas and suggestions from stakeholders.

The upcoming meeting will begin with presentations by NICEATM and ICCVAM members on current activities related to the development and validation of alternative test methods and approaches for assessing acute systemic toxicity, endocrine activity, vaccine safety, and skin sensitization potential, as well as updates on ICCVAM processes. Following each presentation, there will be an opportunity for participants to ask questions of the ICCVAM members. The agenda also includes time for participants to make public oral statements to inform ICCVAM on topics relevant to its mission and current activities.

This meeting is open to the public with time scheduled for oral public statements and for questions following ICCVAM’s and NICEATM’s presentations.

For more information go to http://ntp.niehs.nih.gov/go/iccvamforum-2015

Air date: 5/27/2015 9:00:00 AM


5/7/2015

The NIH Pain Consortium was established to enhance pain research and promote collaboration among researchers across the many NIH Institutes and Centers that have programs and activities addressing pain. The consortium supports initiatives, development of research resources and tools, and hosts events to promote collaboration and highlight advances in pain research.

For more information go to http://painconsortium.nih.gov

Air date: 5/27/2015 8:30:00 AM


5/7/2015

The NIH Pain Consortium was established to enhance pain research and promote collaboration among researchers across the many NIH Institutes and Centers that have programs and activities addressing pain. The consortium supports initiatives, development of research resources and tools, and hosts events to promote collaboration and highlight advances in pain research.

For more information go to http://painconsortium.nih.gov

Air date: 5/26/2015 12:30:00 PM


Up to Top

This page last reviewed: December 14, 2010